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Summary
Introduction
nosocomial infections are a great hospital problem 
as they are associated with an increasing morbidity, 
mortality, and costs. in a one-day prevalence study 
(ePiC study) carried out in 1,417 intensive Care Unit 
(iCU) West europe on more than 10,000 in-patiens, 
the prevalence of infections contracted during hos-
pital stay was 21% [1]. no doubt that the iCUs are 
the departments where infection rate is highest [1], 
being connected with several factors depending either 
on patient (immunodepression, acute or chronic or-
ganic insufficiency, coma, malnutrition, hypotension, 
metabolic acidosis, diabetes, old age) or environment 
(operators hand, non-sterile tools, no glove change, 
contaminated circuits, reservoirs) or therapy (seda-
tion, cortisone and cytotoxic substance, lenghth of 
stay, prolonged or inappropriate use of antibiotics, 
use of anti-acids increasing g-colonisation) [2].
active surveillance protocols were developed based on 
microbiological monitoring of in-patients and hospital 
environments in order to detect those subjects who 
showed greater susceptibility to infections, describe 
the incidence of those infections over time, identify 
epidemics, detect bacteria reservoirs and transmission 
mechanism, start a proper antibiotic therapy and assess 
the efficacy of sanitation procedures [3].
in the last few years, despite remarkable progress to the 
knowledge of risk factors and of prevention and control 
measures, the incidence of nosocomial infections has 
not decreased, also following the outbreak of new mul-
tidrug-resistant pathogenic agents which are selected by 
an excessive and often irrational use of antibiotics [4-6]. 
these micro-organisms are resistant to majority of anti-
biotics in use and even several disinfectants, resulting in 
increased environmental contamination [7-9]. in many 
cases it was demonstrated that the molecular mecha-
nisms responsible for antibiotics-resistance are the same 
implied in “nonsusceptible” to biocides [8].
aim of this study was to assess the efficacy of Umo-
nium38 as biocide on multidrug-resistant strains by 
comparison with a chloride derivative (Decs) widely 
common in clinical sanitation procedures.
Materials and methods
Bacterial strains
environmental epidemic strains (Acinetobacter bau-
mannii, Pseudomonas aeruginosa, Staphilococcus epi-
dermidis Methicillin-resistant, Staphilococcus aureus 
Methicillin-resistant, Enterococcus faecalis High Level 
aminoglycoside resistant, extended-spectrum beta-
lactamase (esBL)-producing Klebsiella pneumoniae, 
Candida albicans) were isolated from 2002 to 2005 
in the intensive Care Units of “Cotugno” Hospital and 
“Federico ii” University Hospital during sanitation 
checks following nosocomial outbreaks. Brain-heart 
moistened swabs were used to sample horizontal surface 
and points of frequent hand contact as well as monitor-
ing equipment, drug trolleys, respirators and washing 
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Introduction. We investigated the efficacy of a biocide Umo-
nium38 on multidrug-resistant strains by comparison with a 
chloride derivative (Decs).
Methods. In vitro susceptibility tests were performed by agar 
diffusion disk and results were interpreted according to Clinical 
and Laboratory Standards Institute (CLSI). In vitro antibacterial 
efficacy of Umonium38 and Decs over selected strains was evalu-
ated according to European Standards protocol with or without 
organic substance.
Results. In vitro tests with Umonium38 at 2.5% concentration 
demonstrated an overall drop in microbial and yeast charges 
after 5 min. contact without organic substance. The same results 
were obtained in presence of organic substance. In vitro tests with 
chloride derivative at 5% without organic substance also resulted 
in overall drop in bacterial and mycotic charges. Conversely, in 
presence of organic substance, the hypochlorite reduced the initial 
108 UFC/ml to 104 UFC/ml for all bacterial strains with a decrease 
of 4 log except for Enterococcus faecalis and Candida albicans 
whose reduction was 2 and 1 log units respectively.
Discussion. The organic substance in water requires large use 
of oxidising disinfectans (chloride, ozone) implying in the need 
for higher-than-standard concentrations. The disinfecting effect 
of chloride is only visible when the “requirement” of organic 
substance has been met. By contrast, Umonium38 behaves like a 
powerful biocide even in presence of organic substance, as it is 
not “consumed” by possible organic residues.
Conclusions. Umonium38 resulted beneficial and effective. It is 
to be stressed, however, that all these experiments were in vitro 
tests and still requires validation from a correct use of clinical 
practice.
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sinks. Contact plates (rodac PBi) with selective agar 
were used to sample the others surfaces (floor, walls, 
beds). Culture specimens were enriched over night at 
37 °C in brain-heart infusion broth and then isolated in 
pure culture on agar plates. environmental isolates were 
identified by a commercial microidentification system 
(API 20E; BioMerieux Marcy-L’Etoile, France).
susceptiBility testing
isolated environmental antibiotypes were determined by 
antibiotic diffusion disk method on Muller Hinton agar ac-
cording to the Clinical and Laboratory standards institute 
(CLsi) criteria for broth microdilution and disk diffusion 
methods [10]. susceptibility or resistance was defined 
using CLsi criteria [10]. esBL activity in K. pneumoniae 
was detected initially by double disk synergy test perfor-
med using cefotaxime, ceftazidime, ceftriaxone, aztreonam 
and amoxicillin-clavulanic acid on Muller Hinton agar 
plates and then by confirmatory test [10]. gentamicin and 
streptomicin disks were used to screen resistance to high 
amino-glycoside resistance in E. faecalis at 120 and 500 
respectively and finally methicillin and vancomycin were 
applied to test these resistance in Staphilococci [10].
Disinfectants
Umonium38 (benzyl-dimethyl-ammonium chloride, iso-
propyl alcohol, lauro-myristic alcohol) and Decs (so-
dium hypochlorite) were used for this study.
solutions of the above disinfectants were prepared by 
diluiting both Umonium38 and the chloride derivative in 
sterile water at the usual hospital concentration (2.5% 
and 5% respectively). the Umonium38 and Decs were as-
sessed by applying the european standards protocol [11] 
with and without organic substance (bovine albumine at 
of 0.3 g/100 ml concentration).
In vItro tests
Bacterial physiological suspensions were prepared from 
fresh cultures of the above micro-organisms, being sub-
cultivated in non-selective media (brain Hearth infusion 
agar for gram-, Enterococcus and Candida, triptone 
soya agar for Staphilococci).
Final concentrations of the bacterial inoculums of 1x 108 
UFC/ml and of 1x  106 UFC/ml for molds were measured 
through a spectrophotometer. Bacterial and yeast 100 µl 
suspensions were added to 900 µl of sterile physiological 
solution (control) and to 900 µl of each one of disinfectant 
solutions in a 25 °C thermostatic bath. each inoculum 
was prepared twice, with and without organic substance. 
after 5 min. incubation, 100 µl were removed from each 
inoculum and soon smeared on Bacto D/e neutralizing 
agar (Becton Dickinson) through serial dilutions. Plates 
were incubated at 37 °C for 24 hours for bacterial strains 
and at 32 °C for 72 hours for mold strain. the test was 
also carried out on glass surfaces initially contaminated 
with the inoculums, for which the same concentrations 
were used as for the suspension test, respectively with and 
without organic substance. after 5 min. sanitation with 
both disinfectants, the surfaces were rinsed with a sterile 
physiological solution and 100 µl were removed from the 
Fig. 1. gram+: in vitro Umonium38 and decs activity in suspension 
and surface tests with or without organic substance.
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rinsing solution and soon smeared on D/e neutralizing 
agar using the serial diluitions. Plates was incubated at the 
same conditions as above.
Results
antimicrobial susceptibility analysis showed a common 
multidrug-resistant antibiotypes for all the isolated mi-
cro-organisms. in particular, the screening evidenced 
extended-spectrum beta-lactamase activity in K. pneu-
moniae with a resistance to third-generation cephalo-
sporins, high amino-glycoside resistance in E. faecalis 
and methicillin-resistance in Staphilococci with either 
positive or negative coagulase.
results of in vitro tests (Figs. 1 and 2) were interpreted 
in agreement to european standards [11]. according to 
e.s. the biocide efficacy must reduce the initial charges 
by 4 o 5 log units and is estimated by micro-organisms 
UFC/ml starting solution-UFC/ml neutralization solu-
tion ratio. In vitro tests with Umonium38 at 2.5% con-
centration demonstrated an overall drop in the microbial 
and yeast charges after 5 min. contact without organic 
substance. the same results were obtained in presence 
of organic substance. in-vitro tests with chloride deri-
vative at 5% without organic substance also resulted in 
Fig. 2. gram-and Mold: in vitro Umonium38 and decs activity in suspension and surface tests with or without organic substance.
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overall drop in bacterial and mycotic charges. Conver-
sely, in presence of organic substance, the hypochlorite 
reduced the initial 108 UFC/ml to 104 UFC/ml for all 
bacterial strains with a decrease of 4 log except for E. 
faecalis (108 UFC/ml to 106 UFC/ml) and C. albicans 
(106 UFC/ml to 105 UFC/ml) whose reduction was 2 and 
1 log units respectively.
Discussion
Umonium38 resulted beneficial and effective (overall drop 
in microbial and yeast charges after 5 minutes contact 
without organic substance used at 2.5% concentration 
and the same results were obtained in presence of organic 
substance ever used at 2.5% concentration) [11].
this can be explained by considering that organic 
substance in water requires large use of oxidising di-
sinfectans (chloride, ozone) implying in the need for 
higher-than-standard concentrations. the disinfecting 
effect of chloride is only visible when the “requirement” 
of organic substance has been met. However, an increa-
se in chloride concentration is not entirely riskless [12]. 
By contrast Umonium38 (quaternary ammonium added 
to isopropyl and lauro-myristic alcohols) behaves like a 
powerful biocide even in presence of organic substance, 
as it is not “consumed” by possible organic residues.
Conclusions
the efficacy of Umonium38 as biocide was assessed in 
this study versus efficacy of a chloride derivative on 
nosocomial multidrug-resistant strains isolated in the 
iCU of “Cotugno” Hospital and “Federico ii” Univer-
sity Hospital during nosocomial outbreaks. in our tests 
Umonium38 resulted beneficial and effective (overall 
drop in microbial and yeast charges after 5 min. contact 
without organic substance used at 2.5% concentration 
and the same results were obtained in presence of or-
ganic substance ever used at 2.5% concentration) [11]. 
it is to be stressed, however, that all these experiments 
were in vitro tests. in the last few years, also following 
an increased circulation of “nonsusceptible” pathogenic 
agents to several disinfectants, the pharmaceutical in-
dustry have developed numerous in vitro tests to assess 
the effectiveness of various biocides in specific clinical 
applications [13, 14]. the Us Food and Drug admini-
stration (FDa) uses surrogate microrganisms and clini-
cal simulation protocols to mimic real-world conditions 
for surgical hand scrubs, preoperative skin solution and 
health care personell hand washes to asses the efficacy 
of topical antiseptics. However, these tests have only a 
predictive significance. the efficacy of the surrogate 
testing methods still requires validation from a correct 
use of clinical practice.
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